Exact Mass: 406.221609
Exact Mass Matches: 406.221609
Found 264 metabolites which its exact mass value is equals to given mass value 406.221609
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lincomycin
C18H34N2O6S (406.21374640000005)
Lincomycin is only found in individuals that have used or taken this drug. It is an antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. [PubChem]Lincomycin inhibits protein synthesis in susceptible bacteria by binding to the 50 S subunits of bacterial ribosomes and preventing peptide bond formation upon transcription. It is usually considered bacteriostatic, but may be bactericidal in high concentrations or when used against highly susceptible organisms. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01F - Macrolides, lincosamides and streptogramins > J01FF - Lincosamides D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Flurogestone Acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone Same as: D04235
Kiwiionoside
Kiwiionoside is found in fruits. Kiwiionoside is a constituent of Actinidia chinensis (kiwifruit). Constituent of Actinidia chinensis (kiwifruit). Kiwiionoside is found in fruits.
Epilincomycin
C18H34N2O6S (406.21374640000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
Fluorogestone acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins
Panduratin A
Xanthoangelol F
Xanthoangelol f is a member of the class of compounds known as 3-prenylated chalcones. 3-prenylated chalcones are chalcones featuring a C5-isoprenoid unit at the 3-position. Thus, xanthoangelol f is considered to be a flavonoid lipid molecule. Xanthoangelol f is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Xanthoangelol f can be found in angelica, which makes xanthoangelol f a potential biomarker for the consumption of this food product.
2,6-Dihydroxy-3-(1-p-menthen-3-yl)-4-methoxychalcone
Heminitidulan
Adunctin C
N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide
C21H28F2N4O2 (406.21802119999995)
(+/-)-isopanduratin A1|4-(2,4-Dihydroxy-6-methoxybenzoyl)-1-methyl-5-phenyl-6-prenylcyclohexene
6-[10-(12,12-dimethyl-13alpha-(22-methyl-21-butenoyloxy)-16-methenylcyclohexyl)ethyl]-naphtalene-1,4-dione|cordiaquinone N
6-[10-(12,12-dimethyl-13alpha-(tigloyloxy)-16-methenylcyclohexyl)ethyl]-naphtalene-1,4-dione|cordiaquinone O
lespeflorin G5
A member of the class of pterocarpans that is (6aR,11aR)-pterocarpan substituted by hydroxy groups at positions 3 and 9, a methyl group at position 8 and prenyl groups at positions 4 and 10. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
COc1ccc(C(=O)C=Cc2ccc(O)cc2)c(O)c1CC=C(/C)CCC=C(C)C
3,5,6-trihydroxydehydro-alpha-ionol 9-O-beta-D-glucopyranoside
Lincomycin
C18H34N2O6S (406.21374640000005)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01F - Macrolides, lincosamides and streptogramins > J01FF - Lincosamides A carbohydrate-containing antibiotic produced by the actinomyces Streptomyces lincolnensis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe, Glycosides, Pyrrolidines CONFIDENCE standard compound; INTERNAL_ID 1180 CONFIDENCE standard compound; INTERNAL_ID 4105 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3687
Lincomycin aka '(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
C19H34O9_beta-D-Glucopyranoside, 3,6-dihydroxy-3-[(1E)-3-hydroxy-1-buten-1-yl]-2,4,4-trimethylcyclohexyl
C19H34O9_2,4-Dihydroxy-4-[(1E)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethylcyclohexyl beta-D-glucopyranoside
Ala Ala Phe Val
Ala Ala Val Phe
Ala Phe Ala Val
Ala Phe Gly Ile
Ala Phe Gly Leu
Ala Phe Ile Gly
Ala Phe Leu Gly
Ala Phe Val Ala
Ala Gly Phe Ile
Ala Gly Phe Leu
Ala Gly Ile Phe
Ala Gly Leu Phe
Ala Ile Phe Gly
Ala Ile Gly Phe
Ala Leu Phe Gly
Ala Leu Gly Phe
Ala Val Ala Phe
Ala Val Phe Ala
Phe Ala Ala Val
Phe Ala Gly Ile
Phe Ala Gly Leu
Phe Ala Ile Gly
Phe Ala Leu Gly
Phe Ala Val Ala
Phe Gly Ala Ile
Phe Gly Ala Leu
Phe Gly Ile Ala
Phe Gly Leu Ala
Phe Ile Ala Gly
Phe Ile Gly Ala
Phe Leu Ala Gly
Phe Leu Gly Ala
Phe Val Ala Ala
Gly Ala Phe Ile
Gly Ala Phe Leu
Gly Ala Ile Phe
Gly Ala Leu Phe
Gly Phe Ala Ile
Gly Phe Ala Leu
Gly Phe Ile Ala
Gly Phe Leu Ala
Gly Ile Ala Phe
Gly Ile Phe Ala
Gly Leu Ala Phe
Gly Leu Phe Ala
Ile Ala Phe Gly
Ile Ala Gly Phe
Ile Phe Ala Gly
Ile Phe Gly Ala
Ile Gly Ala Phe
Ile Gly Phe Ala
Leu Ala Phe Gly
Leu Ala Gly Phe
Leu Phe Ala Gly
Leu Phe Gly Ala
Leu Gly Ala Phe
Leu Gly Phe Ala
Pro Pro Pro Pro
Val Ala Ala Phe
Val Ala Phe Ala
Val Phe Ala Ala
Kiwiionoside
Verucerfont
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal
N-[(2-Cyano[1,1-biphenyl]-4-yl)methyl]-N-(1-oxopentyl)-L-valine methyl ester
1-N,4-N-bis(3,5-dimethylphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
BMS-582949
1,2-bis(ethenyl)benzene,4-butoxy-4-oxobut-2-enoic acid,styrene
1-N,4-N-diphenyl-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide
3,6-diethyl-1-N,4-N-bis(3-methylphenyl)-1,2,4,5-tetrazine-1,4-dicarboxamide
[4-R-(4-alpha,6-beta,7-beta]-Hexahydro-5,6-DI(hydroxy)-1,3-DI(allyl)-4,7-bisphenylmethyl)-2H-1,3-diazepinone
3-Methyl-2-[[4-methyl-2-[(2,3,4,5-tetrahydroxyoxan-2-yl)methylamino]pentanoyl]amino]pentanoic acid
Panduratin A
(2S,4R)-N-[2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
1-Palmitoylglycerone 3-phosphate(2-)
C19H35O7P-2 (406.21202900000003)
a 1-Hexadec-9-enoyl-sn-glycerol 3-phosphate
C19H35O7P-2 (406.21202900000003)
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide
C18H34N2O6S (406.21374640000005)
11-(2-methylpropyl)-3-[2-(morpholin-4-yl)ethyl]-3,11-dihydro-4H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4-one
2-(hydroxymethyl)-6-[(E)-4-(1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl)but-3-en-2-yl]oxyoxane-3,4,5-triol
(2R*,3R*)-3-{[(2S)-1-({4-[(3-aminopropyl)amino]butyl}amino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}oxirane-2-carboxylic acid
(2R*,3R*)-3-{[(2S)-1-({3-[(4-aminobutyl)amino]propyl}amino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}oxirane-2-carboxylic acid
1-Palmitoleoyl-sn-glycerol 3-phosphate(2-)
C19H35O7P-2 (406.21202900000003)
1-[4-(2-Fluorophenyl)-1-piperazinyl]-4-(4,4,6-trimethyl-2-sulfanylidene-1,3-diazinan-1-yl)-1-butanone
(2S)-2-[[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid
(E)-1-[4-hydroxy-2-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
2-[(3R,6aR,8R,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aR,8S,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
N-[2-[(2S,5R,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5R,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
2-[(3S,6aR,8R,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aS,8S,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3S,6aR,8S,10aR)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
N-[2-[(2R,5S,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5R,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2S,5S,6R)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
N-[2-[(2R,5S,6S)-5-[[cyclohexyl(oxo)methyl]amino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-4-fluorobenzamide
2-[(3S,6aS,8S,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3R,6aS,8R,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
2-[(3S,6aS,8R,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-cyclobutylacetamide
[(3aR,4R,9bR)-4-(hydroxymethyl)-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
(2-hydroxy-3-phosphonooxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate
C19H35O7P (406.21202900000003)
(2R,4S)-N-[2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H34N2O6S (406.21374640000005)
TMC-52D
An epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{4-[(3-aminopropyl)amino]butyl}-L-phenylalaninamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52D acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2), with IC50 values of 280 nM, 6 nM, and 49 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S).
TMC-52C
An epoxide which is a carboxamide obtained by the formal condensation of one of the carboxy groups of oxirane-2,3-dicarboxylic acid with N-{3-[(4-aminobutyl)amino]propyl}-L-phenylalaninamide. It is a natural product, isolated from Gliocladium sp. F-2665. TMC-52C acts as an inhibitor of cysteine proteinases, particularly cathepsin B (EC 3.4.22.1), cathepsin L (EC 3.4.22.15), and papain (EC 3.4.22.2), with IC50 values of 460 nM, 10 nM, and 88 nM, respectively. The epoxide group has trans configuration but its exact stereochemistry is uncertain: it is either (2R,3R) or (2S,3S).
1-Palmitoleoyl-sn-glycerol 3-phosphate(2-)
C19H35O7P (406.21202900000003)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmitoleoyl-sn-glycerol 3-phosphate
2-16:1-lysophosphatidate(2-)
C19H35O7P (406.21202900000003)
A 2-acyl-sn-glycero-3-phosphate(2-) in which the acyl group is hexadecenoyl (position of double bond not specified).
1-Palmitoylglycerone 3-phosphate(2-)
C19H35O7P (406.21202900000003)
An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 1-palmitoylglycerone 3-phosphate; major species at pH 7.3.
3-{[1-({4-[(3-aminopropyl)amino]butyl}-c-hydroxycarbonimidoyl)-2-phenylethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid
(2s,4r)-n-[(1s)-2-hydroxy-1-[(3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic acid
C18H34N2O6S (406.21374640000005)
1-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxy-6-methoxyphenyl]-3-phenylprop-2-en-1-one
7-[2-(but-2-en-2-yl)-5-chloro-6-hydroxy-1a,6-dimethyl-octahydronaphtho[1,2-b]oxiren-3-yl]-4-methylhepta-4,6-dien-3-one
C24H35ClO3 (406.22745900000007)